11C-PBR28
11C-PiB
11C-UCB-J PET-CT
11C-methylreboxetine
13C6 Leucine
13N-Ammonia
18-FDG PET
18F-AV-133
18F-AV-1451
18F-AV-1451 (Tau-PET tracer)
18F-AV-45
18F-Dopa
18F-Dopamne
18F-FDG
18F-MK-6240
APOE genotype
APOE genotyping
ASL-MRI
AV1451 Tau
Aftobetin-HCl
All Subjects
Amyvid PET Scan
ApoE
Beta amyloid imaging
Biomarker
Biomarker Data Collection
Biomarker assay
Brain PET scan
Brain imaging examination MRI
C-11 PiB
CSF
Carbidopa 200mg oral dose
Cerebral imaging
Cognitive evaluation
Comprehensive Ophthalmic Examination
Contrast Sensitivity
DVA
DaTSCAN™ Ioflupane (123I) Injection
DaTscan
Desipramine (DMI)
EEG recording
Elecsys (Roche) Abeta42
Electrical Brainstem Responses
Entacapone 400mg oral dose
F-18
F-18 AV 1451
F-18 FDG
F-18 THK-5351
F18-AV-45
FDG-PET
FDOCT
Florbetaben
Florbetapir F 18
Florbetapir F 18 PET Scan
Flortaucipir
Flortaucipir F18
FluoroTau
Fluorodeoxyglucose
Flutemetamol (18F) Injection
Flutemetamol (Vizamyl)
Flutemetamol F18 Injection
Fundus Photography
GE180 PET Scan
Gait Assessment
I-123 Ioflupane solution injection prior to SPECT scan (DaTscan)
LY3191748
Lodosyn
Lumbar punction
Lumipulse (Fujirebio) Abeta42
MRI Brain Imaging
MRI Scan
MRI acquisition
MRI and CSF
MRI exam of the brain
MRI imaging
MRI scan
Magnetic Resonance Imaging (MRI)
Mental Health Assessment and Computerized Cognitive Test
Neuraceq
Neurological assessments
Neuropsychiatric testing
Noninvasive Retinal Amyloid Imaging (NRAI)
Observational Study
Olfactory Tests
Ophthalmological exam
Optical Coherence Tomography Angiography (OCTA) Imaging
PET Scan
PET scan
PET scan & fMRI
Pattern ERG
Pittsburgh Compound B (C-11 PiB)
Polysomnogram
Positron Emission Tomography
Positron Emission Tomography (PET)
Positron emission tomography
Pramlintide challenge test
Radiopharmaceuticals
Retinal Imaging
Retinal fundus photography
Saliva samples
Sapphire II
Siemens "Biograph mMR" PET-MR (3T)
Single photon emission computed tomography (SPECT) scan
Spectral-Domain Optical Coherence Tomography (SD-OCT)
T807
T807 PET scan
Tau (18-F-AV-1451)
Ttau and Ptau
Visual Deprivation
Vizamyl
[11C]MPC6827
[123I]-IBVM
[123I]CLINDE
[123I]MNI-420
[123I]β-CIT
[18F] CFPyPB
[18F] Flutemetamol
[18F] PBR06
[18F]-FEPPA
[18F]-PI2620
[18F]-RO6958948
[18F]AV-1451
[18F]AV-45 PET
[18F]DPA-714 PET/ [18F]AV-45 PET/neuropsychological assessment
[18F]FDOPA
[18F]FPEB
[18F]Flutemetamol
[18F]MK-6240
[18F]MNI-1126
[18F]MNI-815 (MNI-815)
[18F]NAV4694
[18F]PI-2620
[18F]T807 ([18F]MNI-777)
[18F]THK-5351
[18F]flutemetamol PET scan
[F-18]FDDNP-PET
[F-18]PBR06
[F-18]T807
[F18]-FDDNP
[F18]T807
administration of stable isotope-labelled leucine-
behavioral evaluations
biomarkers
blood and urine sampling
characterization
clinical measures of disease severity and progression
collection of CSF
colonoscopy or rectosigmoidoscopy
florbetapir (18F)
florbetapir 18F
florbetapir F 18
multimodal retinal imaging
neuropsychologic assessment
non-invasive retinal imaging
punch skin biopsy
saliva
urine
~160 MBq
~185 MBq
